Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma

被引:216
作者
Inoue, K
Makuuchi, M
Takayama, T
Torzilli, G
Yamamoto, J
Shimada, K
Kosuge, T
Yamasaki, S
Konishi, M
Kinoshita, T
Miyagawa, S
Kawasaki, S
机构
[1] Univ Tokyo, Grad Sch Med, Hepato Biliary Pancreat Surg Div, Artificial Organ & Transplantat Div,Bunkyo Ku, Tokyo 1138655, Japan
[2] Natl Canc Ctr, Hepato Biliary Pancreat Surg Div, Tokyo 104, Japan
[3] Natl Canc Ctr E, Chiba, Japan
[4] Shinshu Univ, Sch Med, Dept Surg 1, Matsumoto, Nagano, Japan
关键词
D O I
10.1067/msy.2000.104673
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Mass-forming type cholangiocarcinoma is a distinct form of cholangiocellular carcinoma, with pathologic and biologic behavior different from those of other types. The clinical consequences of these differences have never been clarified. Methods. Fifty-two consecutive patients (32 men and 20 women, mean age 62 years) with mass-forming type cholangiocarcinoma that had been treated with curative surgical resection between 1980 and 1998 were retrospectively evaluated. Long-term survival and disease-free survival were calculated, and univariate and multivariate analysis of various prognostic factors was conducted. Results. The 30-day postoperative mortality rate was 2 %, and the overall and disease-free 5-year survival rates were 36% and 34 %, respectively. Univariate analysis identified 5 significant risk factors for overall survival: surgical margin, lymph node metastasis, lymph node dissection, vascular invasion, and left-side location of the main tumor Two risk factors were identified for disease-free survival: surgical margin and lymph node metastasis. Multivariate analysis confirmed that surgical margin, lymph node metastasis, and vascular invasion were independently significant variables for overall survival. Conclusions This is the first reported study on the effectiveness of liver resection for the treatment of mass-forming type cholangiocarcinoma, showing that surgical therapy can prolong survival if local radicality can be achieved and lymph-node metastases are absent.
引用
收藏
页码:498 / 505
页数:8
相关论文
共 51 条
  • [1] CANCER OF BILE-DUCTS ASSOCIATED WITH ULCERATIVE-COLITIS
    AKWARI, OE
    VANHEERDEN, JA
    FOULK, WT
    BAGGENSTOSS, AH
    [J]. ANNALS OF SURGERY, 1975, 181 (03) : 303 - 309
  • [2] BELAMARIC J, 1973, CANCER-AM CANCER SOC, V31, P468, DOI 10.1002/1097-0142(197302)31:2<468::AID-CNCR2820310226>3.0.CO
  • [3] 2-J
  • [4] A western surgical experience of peripheral cholangiocarcinoma
    Berdah, SV
    Delpero, JR
    Garcia, S
    Hardwigsen, J
    LeTreut, YP
    [J]. BRITISH JOURNAL OF SURGERY, 1996, 83 (11) : 1517 - 1521
  • [5] Hepatic resection and transplantation for peripheral cholangiocarcinoma
    Casavilla, FA
    Marsh, JW
    Iwatsuki, S
    Todo, S
    Lee, RG
    Madariaga, JR
    Pinna, A
    Dvorchik, I
    Fung, JJ
    Starzl, TE
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1997, 185 (05) : 429 - 436
  • [6] CHOLANGIOCARCINOMA IN HEPATOLITHIASIS
    CHEN, PH
    LO, HW
    WANG, CS
    TSAI, KR
    CHEN, YC
    LIN, KY
    SIAUW, CP
    HWANG, RR
    LIU, MH
    KO, HC
    CHEN, TY
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1984, 6 (06) : 539 - 547
  • [7] CHERQUI D, 1995, ARCH SURG-CHICAGO, V130, P1073
  • [8] Intrahepatic cholangiocarcinoma
    Chu, KM
    Lai, ECS
    AlHadeedi, S
    Arcilla, CE
    Lo, CM
    Liu, CL
    Fan, ST
    Wong, J
    [J]. WORLD JOURNAL OF SURGERY, 1997, 21 (03) : 301 - 306
  • [9] Chuo FF, 1997, HEPATO-GASTROENTEROL, V44, P760
  • [10] COUINAUD C, 1957, FOIE ETUDES ANAT CHI